{"id":522136,"date":"2021-08-03T08:33:38","date_gmt":"2021-08-03T12:33:38","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/foghorn-therapeutics-to-participate-at-the-2021-wedbush-pacgrow-healthcare-virtual-conference\/"},"modified":"2021-08-03T08:33:38","modified_gmt":"2021-08-03T12:33:38","slug":"foghorn-therapeutics-to-participate-at-the-2021-wedbush-pacgrow-healthcare-virtual-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/foghorn-therapeutics-to-participate-at-the-2021-wedbush-pacgrow-healthcare-virtual-conference\/","title":{"rendered":"Foghorn Therapeutics to Participate at the 2021 Wedbush PacGrow Healthcare Virtual Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">CAMBRIDGE, Mass., Aug.  03, 2021  (GLOBE NEWSWIRE) &#8212; Foghorn Therapeutics Inc. (Nasdaq: FHTX), a company pioneering the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system, today announced that Steven Bellon, Ph.D., Senior Vice President of Drug Discovery, is scheduled to participate in a panel at the 2021 Wedbush PacGrow Healthcare Virtual Conference, which is being held from August 10-11.<\/p>\n<p align=\"justify\">\n        <strong>Panel Details:<br \/><\/strong><br \/>\n        <strong>Title:<\/strong> \u201cBullseye \u2013 Targeted Oncology Part 2\u201d<br \/><strong>Panel date and time: <\/strong>Wednesday, August 11, 10:20 a.m. ET<\/p>\n<p>Members of the Foghorn management team will also host investor meetings during the conference.<\/p>\n<p>A live webcast of the panel can be accessed under \u201cEvents &amp; Presentations\u201d in the Investors section of the Company\u2019s website, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=YwL5x-DQghSFdcwW2MQrrt0ixaqhTMV6leFxLCVQnIFDgmADtcE-Ho3Vb7O4MM1EoWgMX6xZ4jivtm26EiUwfw==\" rel=\"nofollow noopener\" target=\"_blank\">www.foghorntx.com<\/a>.<\/p>\n<p>\n        <strong>About Foghorn Therapeutics <\/strong>\n      <\/p>\n<p>Foghorn\u00ae Therapeutics is discovering and developing a novel class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Through its proprietary scalable Gene Traffic Control\u00ae platform, Foghorn is systematically studying, identifying and validating potential drug targets within the chromatin regulatory system. The company is developing multiple product candidates in oncology.<\/p>\n<p>\n        <strong>Media Contact: <\/strong>\n      <\/p>\n<p>Fanny Cavali\u00e9, Foghorn Therapeutics <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=0KpMHyoTSXSTrQasOKtQFsivHikNsnsCyChF64_qpeazav-cdlCWxAuTgExmTnoC61iDh4yl-OOJksgot_eFwY73xA5whaVndthCffazkdo=\" rel=\"nofollow noopener\" target=\"_blank\">fcavalie@foghorntx.com<\/a><\/p>\n<p>Gregory Kelley, Ogilvy <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Y-oX7TqJQAIf7gFLqhOEEoZ0How-p1e_S8Ne3tOuYaxxwxXDWOcmVNMnkKWrmPvH5IKYOFzOCYuAZsqXqRHwpR1SFgtGspcrjPhm4EVpsUU=\" rel=\"nofollow noopener\" target=\"_blank\">gregory.kelley@ogilvy.com<\/a><\/p>\n<p>\n        <strong>Investor Relations Contact: <\/strong>\n      <\/p>\n<p>Allan Reine, Foghorn Therapeutics <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=FhWtRAzb9eeBBHwkKbsOYOwkGRwOimKsOgM0K-t3YHTvUtMdoPhxmToRgHpyMeIk8YNyPsQ4vjF1hwOm-PxYfNeFlXXUDISIFv_BG2xpJss=\" rel=\"nofollow noopener\" target=\"_blank\">areine@foghorntx.com<\/a><\/p>\n<p>Hans Vitzthun, LifeSci Advisors<br \/>617-430-7578<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=elSyAyaHl8CJTkO_Qibj3mW9pZoXgGmIgDoRKNe6KejGlZg74Owlw39o5mf078lIOcMO-mw8qn97gVgcsftF6T3hnWJoGKevaPyc5PzWD08=\" rel=\"nofollow noopener\" target=\"_blank\">hans@lifesciadvisors.com<\/a><\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMTM5OCM0MzM3MzU4IzIyMDI4NjI=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/08709b50-a625-4d56-96df-00544df2783d\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>CAMBRIDGE, Mass., Aug. 03, 2021 (GLOBE NEWSWIRE) &#8212; Foghorn Therapeutics Inc. (Nasdaq: FHTX), a company pioneering the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system, today announced that Steven Bellon, Ph.D., Senior Vice President of Drug Discovery, is scheduled to participate in a panel at the 2021 Wedbush PacGrow Healthcare Virtual Conference, which is being held from August 10-11. Panel Details: Title: \u201cBullseye \u2013 Targeted Oncology Part 2\u201dPanel date and time: Wednesday, August 11, 10:20 a.m. ET Members of the Foghorn management team will also host investor meetings during the conference. A live webcast of the panel can be accessed under \u201cEvents &amp; Presentations\u201d in the Investors section of the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/foghorn-therapeutics-to-participate-at-the-2021-wedbush-pacgrow-healthcare-virtual-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Foghorn Therapeutics to Participate at the 2021 Wedbush PacGrow Healthcare Virtual Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-522136","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Foghorn Therapeutics to Participate at the 2021 Wedbush PacGrow Healthcare Virtual Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/foghorn-therapeutics-to-participate-at-the-2021-wedbush-pacgrow-healthcare-virtual-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Foghorn Therapeutics to Participate at the 2021 Wedbush PacGrow Healthcare Virtual Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"CAMBRIDGE, Mass., Aug. 03, 2021 (GLOBE NEWSWIRE) &#8212; Foghorn Therapeutics Inc. (Nasdaq: FHTX), a company pioneering the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system, today announced that Steven Bellon, Ph.D., Senior Vice President of Drug Discovery, is scheduled to participate in a panel at the 2021 Wedbush PacGrow Healthcare Virtual Conference, which is being held from August 10-11. Panel Details: Title: \u201cBullseye \u2013 Targeted Oncology Part 2\u201dPanel date and time: Wednesday, August 11, 10:20 a.m. ET Members of the Foghorn management team will also host investor meetings during the conference. A live webcast of the panel can be accessed under \u201cEvents &amp; Presentations\u201d in the Investors section of the &hellip; Continue reading &quot;Foghorn Therapeutics to Participate at the 2021 Wedbush PacGrow Healthcare Virtual Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/foghorn-therapeutics-to-participate-at-the-2021-wedbush-pacgrow-healthcare-virtual-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-08-03T12:33:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMTM5OCM0MzM3MzU4IzIyMDI4NjI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/foghorn-therapeutics-to-participate-at-the-2021-wedbush-pacgrow-healthcare-virtual-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/foghorn-therapeutics-to-participate-at-the-2021-wedbush-pacgrow-healthcare-virtual-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Foghorn Therapeutics to Participate at the 2021 Wedbush PacGrow Healthcare Virtual Conference\",\"datePublished\":\"2021-08-03T12:33:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/foghorn-therapeutics-to-participate-at-the-2021-wedbush-pacgrow-healthcare-virtual-conference\\\/\"},\"wordCount\":223,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/foghorn-therapeutics-to-participate-at-the-2021-wedbush-pacgrow-healthcare-virtual-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMwMTM5OCM0MzM3MzU4IzIyMDI4NjI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/foghorn-therapeutics-to-participate-at-the-2021-wedbush-pacgrow-healthcare-virtual-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/foghorn-therapeutics-to-participate-at-the-2021-wedbush-pacgrow-healthcare-virtual-conference\\\/\",\"name\":\"Foghorn Therapeutics to Participate at the 2021 Wedbush PacGrow Healthcare Virtual Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/foghorn-therapeutics-to-participate-at-the-2021-wedbush-pacgrow-healthcare-virtual-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/foghorn-therapeutics-to-participate-at-the-2021-wedbush-pacgrow-healthcare-virtual-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMwMTM5OCM0MzM3MzU4IzIyMDI4NjI=\",\"datePublished\":\"2021-08-03T12:33:38+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/foghorn-therapeutics-to-participate-at-the-2021-wedbush-pacgrow-healthcare-virtual-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/foghorn-therapeutics-to-participate-at-the-2021-wedbush-pacgrow-healthcare-virtual-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/foghorn-therapeutics-to-participate-at-the-2021-wedbush-pacgrow-healthcare-virtual-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMwMTM5OCM0MzM3MzU4IzIyMDI4NjI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMwMTM5OCM0MzM3MzU4IzIyMDI4NjI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/foghorn-therapeutics-to-participate-at-the-2021-wedbush-pacgrow-healthcare-virtual-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Foghorn Therapeutics to Participate at the 2021 Wedbush PacGrow Healthcare Virtual Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Foghorn Therapeutics to Participate at the 2021 Wedbush PacGrow Healthcare Virtual Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/foghorn-therapeutics-to-participate-at-the-2021-wedbush-pacgrow-healthcare-virtual-conference\/","og_locale":"en_US","og_type":"article","og_title":"Foghorn Therapeutics to Participate at the 2021 Wedbush PacGrow Healthcare Virtual Conference - Market Newsdesk","og_description":"CAMBRIDGE, Mass., Aug. 03, 2021 (GLOBE NEWSWIRE) &#8212; Foghorn Therapeutics Inc. (Nasdaq: FHTX), a company pioneering the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system, today announced that Steven Bellon, Ph.D., Senior Vice President of Drug Discovery, is scheduled to participate in a panel at the 2021 Wedbush PacGrow Healthcare Virtual Conference, which is being held from August 10-11. Panel Details: Title: \u201cBullseye \u2013 Targeted Oncology Part 2\u201dPanel date and time: Wednesday, August 11, 10:20 a.m. ET Members of the Foghorn management team will also host investor meetings during the conference. A live webcast of the panel can be accessed under \u201cEvents &amp; Presentations\u201d in the Investors section of the &hellip; Continue reading \"Foghorn Therapeutics to Participate at the 2021 Wedbush PacGrow Healthcare Virtual Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/foghorn-therapeutics-to-participate-at-the-2021-wedbush-pacgrow-healthcare-virtual-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2021-08-03T12:33:38+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMTM5OCM0MzM3MzU4IzIyMDI4NjI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/foghorn-therapeutics-to-participate-at-the-2021-wedbush-pacgrow-healthcare-virtual-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/foghorn-therapeutics-to-participate-at-the-2021-wedbush-pacgrow-healthcare-virtual-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Foghorn Therapeutics to Participate at the 2021 Wedbush PacGrow Healthcare Virtual Conference","datePublished":"2021-08-03T12:33:38+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/foghorn-therapeutics-to-participate-at-the-2021-wedbush-pacgrow-healthcare-virtual-conference\/"},"wordCount":223,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/foghorn-therapeutics-to-participate-at-the-2021-wedbush-pacgrow-healthcare-virtual-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMTM5OCM0MzM3MzU4IzIyMDI4NjI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/foghorn-therapeutics-to-participate-at-the-2021-wedbush-pacgrow-healthcare-virtual-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/foghorn-therapeutics-to-participate-at-the-2021-wedbush-pacgrow-healthcare-virtual-conference\/","name":"Foghorn Therapeutics to Participate at the 2021 Wedbush PacGrow Healthcare Virtual Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/foghorn-therapeutics-to-participate-at-the-2021-wedbush-pacgrow-healthcare-virtual-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/foghorn-therapeutics-to-participate-at-the-2021-wedbush-pacgrow-healthcare-virtual-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMTM5OCM0MzM3MzU4IzIyMDI4NjI=","datePublished":"2021-08-03T12:33:38+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/foghorn-therapeutics-to-participate-at-the-2021-wedbush-pacgrow-healthcare-virtual-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/foghorn-therapeutics-to-participate-at-the-2021-wedbush-pacgrow-healthcare-virtual-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/foghorn-therapeutics-to-participate-at-the-2021-wedbush-pacgrow-healthcare-virtual-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMTM5OCM0MzM3MzU4IzIyMDI4NjI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMTM5OCM0MzM3MzU4IzIyMDI4NjI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/foghorn-therapeutics-to-participate-at-the-2021-wedbush-pacgrow-healthcare-virtual-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Foghorn Therapeutics to Participate at the 2021 Wedbush PacGrow Healthcare Virtual Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/522136","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=522136"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/522136\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=522136"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=522136"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=522136"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}